| Added Value of O-RADS in Evaluation of Ovarian Lesions (NCT04579575) | Assiut University | 2021-12-20 |
| A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) (NCT05001282) | Elucida Oncology | 2021-09-13 |
| Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer (NCT04807166) | Wenjun Cheng | 2021-08-24 |
| Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer (NCT04519151) | Sheba Medical Center | 2021-04-12 |
| Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (NCT04556071) | Xiaoxiang Chen | 2020-11-06 |
| Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer (NCT04566952) | Xiaoxiang Chen | 2020-10-28 |
| Turner Syndrome Minipuberty Study (NCT04189406) | Radboud University Medical Center | 2020-02-01 |
| Ovarian Reserve and Ankylosing Spondylitis (NCT04209881) | Kanuni Sultan Suleyman Training and Research Hospital | 2019-12-19 |
| Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer (NCT03562897) | Catalysis SL | 2018-10-25 |
| Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy (NCT03593681) | Boston Scientific Corporation | 2018-08-27 |
| Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer (NCT02973750) | H. Lee Moffitt Cancer Center and Research Institute | 2016-10-20 |
| 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients (NCT01832116) | University Medical Center Groningen | 2013-03-01 |
| Feasability Study of Removing the Ovaries and Fallopian Tubes (NCT01566955) | Heidelberg University | 2012-04-01 |
| Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer (NCT01462890) | AGO Study Group | 2011-11-01 |
| Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma (NCT01460979) | AGO Study Group | 2011-10-01 |
| Antral Follicle Priming Prior to ICSI (Intracytoplasmic Sperm Injection) in Previously Diagnosed Low Responders (NCT01310647) | Instituto de Investigacion Sanitaria La Fe | 2011-06-01 |
| A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer (NCT01016054) | Astellas Pharma Inc | 2009-10-01 |
| A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer (NCT00816764) | Astellas Pharma Inc | 2008-10-01 |
| A Study of Trabectedin in Patients With Advanced Ovarian Cancer (NCT00050414) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-10-01 |
| Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment (NCT00210249) | Institut Bergonié | 2002-09-01 |